大葉大學圖書館 |

Magnetic resonance spectroscopy of degenerative brain diseases[electronic resource] /

紀錄類型:	書目-電子資源 : Monograph/item
杜威分類號:	616.8047548
書名/作者:	Magnetic resonance spectroscopy of degenerative brain diseases/ edited by Gulin Oz.
其他作者:	Oz, Gulin.
出版者:	Cham : : Springer International Publishing :, 2016.
面頁冊數:	xv, 268 p. : : ill. (some col.), digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Brain - Degeneration
標題:	Biomedicine.
標題:	Neurosciences.
標題:	Neurology.
ISBN:	9783319335551
ISBN:	9783319335537
內容註:	Imaging Neurodegeneration: What can Magnetic Resonance Spectroscopy Contribute? -- Methodology of MRS in animal models: Technical challenges and solutions -- Methodology of clinical MRS: Technical challenges and solutions -- Magnetic Resonance Spectroscopy in Dementia -- Magnetic Resonance Spectroscopy in Parkinsonian Disorders -- Magnetic Resonance Spectroscopy in Huntington's Disease -- Magnetic Resonance Spectroscopy in Motor Neuron Diseases -- Magnetic Resonance Spectroscopy in Multiple Sclerosis -- Magnetic Resonance Spectroscopy in Ataxias -- Magnetic Resonance Spectroscopy in Prion Diseases -- Magnetic Resonance Spectroscopy in HIV-Associated Neurocognitive Disorders (HAND) -- Magnetic Resonance Spectroscopy in Epilepsy.
摘要、提要註:	The proposed book will act as a guide for scientists and clinicians to the unique information that MRS can provide. It will be a comprehensive overview of clinical and pre-clinical MRS applications and potential clinical utility of MRS biomarkers in degenerative brain diseases from leading experts in the field. MRS has proven to be a powerful complementary tool to MRI for the diagnosis and monitoring of disease progression and response to treatment because it can detect changes in cell density, cell type, and biochemical composition, not just structural changes. As the population in the developed world continues to age, neuroimaging for diagnosis, prognosis, and therapy monitoring of neurodegenerative diseases becomes increasingly important and there has been a recent surge of clinical and pre-clinical applications of MRS indicating that this technique can provide robust and non-invasive biomarkers of degeneration.
電子資源:	http://dx.doi.org/10.1007/978-3-319-33555-1

Magnetic resonance spectroscopy of degenerative brain diseases[electronic resource] /
Magnetic resonance spectroscopy of degenerative brain diseases[electronic resource] /edited by Gulin Oz. - Cham :Springer International Publishing :2016. - xv, 268 p. :ill. (some col.), digital ;24 cm. - Contemporary clinical neuroscience. - Contemporary clinical neuroscience..

Imaging Neurodegeneration: What can Magnetic Resonance Spectroscopy Contribute? -- Methodology of MRS in animal models: Technical challenges and solutions -- Methodology of clinical MRS: Technical challenges and solutions -- Magnetic Resonance Spectroscopy in Dementia -- Magnetic Resonance Spectroscopy in Parkinsonian Disorders -- Magnetic Resonance Spectroscopy in Huntington's Disease -- Magnetic Resonance Spectroscopy in Motor Neuron Diseases -- Magnetic Resonance Spectroscopy in Multiple Sclerosis -- Magnetic Resonance Spectroscopy in Ataxias -- Magnetic Resonance Spectroscopy in Prion Diseases -- Magnetic Resonance Spectroscopy in HIV-Associated Neurocognitive Disorders (HAND) -- Magnetic Resonance Spectroscopy in Epilepsy.

The proposed book will act as a guide for scientists and clinicians to the unique information that MRS can provide. It will be a comprehensive overview of clinical and pre-clinical MRS applications and potential clinical utility of MRS biomarkers in degenerative brain diseases from leading experts in the field. MRS has proven to be a powerful complementary tool to MRI for the diagnosis and monitoring of disease progression and response to treatment because it can detect changes in cell density, cell type, and biochemical composition, not just structural changes. As the population in the developed world continues to age, neuroimaging for diagnosis, prognosis, and therapy monitoring of neurodegenerative diseases becomes increasingly important and there has been a recent surge of clinical and pre-clinical applications of MRS indicating that this technique can provide robust and non-invasive biomarkers of degeneration.

ISBN: 9783319335551

Standard No.: 10.1007/978-3-319-33555-1doiSubjects--Topical Terms:

666101
Brain
--Degeneration

LC Class. No.: RC394.D35

Dewey Class. No.: 616.8047548

Magnetic resonance spectroscopy of degenerative brain diseases[electronic resource] /
LDR:02682nmm a2200325 a 4500 001 461934
003 DE-He213
005 20161212162951.0
006 m d
007 cr nn 008maaau
008 170223s2016 gw s 0 eng d
020 $a 9783319335551 $q (electronic bk.)
020 $a 9783319335537 $q (paper)
024 7 $a 10.1007/978-3-319-33555-1 $2 doi
035 $a 978-3-319-33555-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC394.D35
072 7 $a PSAN $2 bicssc
072 7 $a MED057000 $2 bisacsh
082 0 4 $a 616.8047548 $2 23
090 $a RC394.D35 $b M196 2016
245 0 0 $a Magnetic resonance spectroscopy of degenerative brain diseases $h [electronic resource] / $c edited by Gulin Oz.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xv, 268 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Contemporary clinical neuroscience
505 0 $a Imaging Neurodegeneration: What can Magnetic Resonance Spectroscopy Contribute? -- Methodology of MRS in animal models: Technical challenges and solutions -- Methodology of clinical MRS: Technical challenges and solutions -- Magnetic Resonance Spectroscopy in Dementia -- Magnetic Resonance Spectroscopy in Parkinsonian Disorders -- Magnetic Resonance Spectroscopy in Huntington's Disease -- Magnetic Resonance Spectroscopy in Motor Neuron Diseases -- Magnetic Resonance Spectroscopy in Multiple Sclerosis -- Magnetic Resonance Spectroscopy in Ataxias -- Magnetic Resonance Spectroscopy in Prion Diseases -- Magnetic Resonance Spectroscopy in HIV-Associated Neurocognitive Disorders (HAND) -- Magnetic Resonance Spectroscopy in Epilepsy.
520 $a The proposed book will act as a guide for scientists and clinicians to the unique information that MRS can provide. It will be a comprehensive overview of clinical and pre-clinical MRS applications and potential clinical utility of MRS biomarkers in degenerative brain diseases from leading experts in the field. MRS has proven to be a powerful complementary tool to MRI for the diagnosis and monitoring of disease progression and response to treatment because it can detect changes in cell density, cell type, and biochemical composition, not just structural changes. As the population in the developed world continues to age, neuroimaging for diagnosis, prognosis, and therapy monitoring of neurodegenerative diseases becomes increasingly important and there has been a recent surge of clinical and pre-clinical applications of MRS indicating that this technique can provide robust and non-invasive biomarkers of degeneration.
650 0 $a Brain $x Degeneration $x Magnetic resonance imaging. $3 666101
650 1 4 $a Biomedicine. $3 463454
650 2 4 $a Neurosciences. $3 372208
650 2 4 $a Neurology. $3 402687
700 1 $a Oz, Gulin. $3 666100
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
830 0 $a Contemporary clinical neuroscience. $3 605180
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-33555-1
950 $a Biomedical and Life Sciences (Springer-11642)